Which outcome can be a result of paradoxical bronchospasm?

Paradoxical bronchospasm refers to a situation where, instead of improving, a bronchodilator medication, which is intended to relieve bronchospasm, leads to the constriction of the airways. As a result, patients may experience increased respiratory distress due to the worsening of airflow obstruction.

This can manifest as symptoms like wheezing, coughing, increased shortness of breath, and a feeling of tightness in the chest. The occurrence of paradoxical bronchospasm can be particularly alarming as it negates the intended therapeutic effects of the medication, thus escalating the patient's respiratory challenge. Understanding this adverse reaction is vital for effective asthma management and ensuring that patients receive the appropriate treatment without experiencing exacerbated symptoms.

In contrast, other potential outcomes such as improved lung function, decreased inflammation, and greater airway dilation would not align with the definition of paradoxical bronchospasm, where the response to treatment is counterproductive and results in increased difficulties in breathing.